Best LC et al. |
The interrelationship between thromboxane biosynthesis, aggregation and 5-hydroxytryptamine secretion in human platelets in vitro. |
1980 |
Thromb. Haemost. |
pmid:6773171
|
Miller KW and Keith JC |
Effect of thromboxane synthetase inhibition on platelet function and morphology during ovine pregnancy-induced hypertension. |
1988 |
Thromb. Haemost. |
pmid:3238644
|
Joseph S et al. |
Effect of the polyamine-spermine on agonist-induced human platelet activation--specific inhibition of "aggregation-independent" events induced by thrombin, but not by collagen, thromboxane mimetic, phorbol ester or calcium ionophore. |
1987 |
Thromb. Haemost. |
pmid:3110996
|
Hansen JB et al. |
The effect of lipopolysaccharides (LPS) on generation of thromboxane A2 and thromboplastin activity in whole blood of males, females and females on oral contraceptives. |
1989 |
Thromb. Haemost. |
pmid:2799762
|
Siess W et al. |
Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation. |
1981 |
Thromb. Haemost. |
pmid:7025338
|
Watanabe J et al. |
Effect of vitamin E on platelet aggregation in diabetes mellitus. |
1984 |
Thromb. Haemost. |
pmid:6495252
|
Matsumoto M et al. |
Thromboxane generation in patients with essential hypertension or cerebrovascular disease and effect of oral aspirin. |
1980 |
Thromb. Haemost. |
pmid:7423441
|
Spectre G et al. |
Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications. |
2011 |
Thromb. Haemost. |
pmid:21800009
|
Gresele P et al. |
Picotamide protects mice from death in a pulmonary embolism model by a mechanism independent from thromboxane suppression. |
1990 |
Thromb. Haemost. |
pmid:2274931
|
Scharf RE |
In vitro thromboxane synthesis of depleted blood platelets following renal transplantation. |
1990 |
Thromb. Haemost. |
pmid:2148845
|
Hoet B et al. |
Ridogrel, a combined thromboxane synthase inhibitor and receptor blocker, decreases elevated plasma beta-thromboglobulin levels in patients with documented peripheral arterial disease. |
1990 |
Thromb. Haemost. |
pmid:2148849
|
Cattaneo M et al. |
Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium. |
1985 |
Thromb. Haemost. |
pmid:3927505
|
Crescente M et al. |
Gallic acid, a dietary polyphenolic component, blunts the inhibition of platelet COX-1 by aspirin: preliminary in-vitro findings. |
2007 |
Thromb. Haemost. |
pmid:17549313
|
Undas A et al. |
Lack of aspirin-induced decrease in thrombin formation in subjects resistant to aspirin. |
2007 |
Thromb. Haemost. |
pmid:17549314
|
Perneby C et al. |
Dose- and time-dependent antiplatelet effects of aspirin. |
2006 |
Thromb. Haemost. |
pmid:16601836
|
Hampton KK et al. |
Coagulation, fibrinolytic and platelet function in patients on long-term therapy with aspirin 300 mg or 1,200 mg daily compared with placebo. |
1990 |
Thromb. Haemost. |
pmid:2073296
|
Dragani A et al. |
Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism. |
2012 |
Thromb. Haemost. |
pmid:22782530
|
Gordge MP et al. |
Platelet function and the bleeding time in progressive renal failure. |
1988 |
Thromb. Haemost. |
pmid:3187950
|
D'Angelo A et al. |
Effect of des-amino-D-arginine vasopressin (DDAVP) on plasma levels of platelet and endothelial cell release products. |
1983 |
Thromb. Haemost. |
pmid:6687766
|
Vezza R et al. |
Antivasoconstrictor and antiaggregatory activities of picotamide unrelated to thromboxane A2 antagonism. |
1997 |
Thromb. Haemost. |
pmid:9408024
|
Han P et al. |
Verapamil and collagen-induced platelet reactions--evidence for a role for intracellular calcium in platelet activation. |
1983 |
Thromb. Haemost. |
pmid:6415847
|
Guthikonda S et al. |
Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy. |
2008 |
Thromb. Haemost. |
pmid:18612542
|
Gresele P et al. |
Platelet activation markers in patients with peripheral arterial disease--a prospective comparison of different platelet function tests. |
1997 |
Thromb. Haemost. |
pmid:9423790
|
Naesh O et al. |
Platelet function in surgical stress. |
1985 |
Thromb. Haemost. |
pmid:2935969
|
Davì G et al. |
The effect of two low doses of aspirin on whole blood thromboxane and prostacyclin generation in healthy subjects. |
1983 |
Thromb. Haemost. |
pmid:6417815
|
Michelson AD et al. |
Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. |
1994 |
Thromb. Haemost. |
pmid:7522354
|
Hornby EJ et al. |
The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion. |
1989 |
Thromb. Haemost. |
pmid:2529661
|
Husted SE et al. |
Intravenous acetylsalicylic acid--dose-related effects on platelet function and fibrinolysis in healthy males. |
1992 |
Thromb. Haemost. |
pmid:1412171
|
Subbiah MT et al. |
Studies of aggregation and thromboxane B2 synthesis in avian thrombocytes: comparison between atherosclerosis-susceptible and resistant breeds. |
1980 |
Thromb. Haemost. |
pmid:7455983
|
Halawani SH et al. |
Aspirin failure in patients presenting with acute cerebrovascular ischaemia. |
2011 |
Thromb. Haemost. |
pmid:21544317
|
Patrono C et al. |
Characterization of biochemical and functional effects of antiplatelet drugs as a key to their clinical development. |
1995 |
Thromb. Haemost. |
pmid:8578493
|
Cortellaro M et al. |
Transcoronary platelet thromboxane A2 formation without platelet trapping in patients with coronary stenosis-effect of sulphinpyrazone treatment. |
1983 |
Thromb. Haemost. |
pmid:6665767
|
Szczeklik A et al. |
Prolonged bleeding time, reduced platelet aggregation, altered PAF-acether sensitivity and increased platelet mass are a trait of asthma and hay fever. |
1986 |
Thromb. Haemost. |
pmid:3563961
|
Falcon CR et al. |
The in vitro production of thromboxane B2 by platelets of diabetic patients is normal at physiological concentrations of ionized calcium. |
1993 |
Thromb. Haemost. |
pmid:8259535
|
Fruzzetti F et al. |
Platelet-vessel wall interactions with third-generation oral contraceptives: no evidence of detrimental effects. |
1999 |
Thromb. Haemost. |
pmid:10494782
|
Cattaneo M et al. |
Conditions influencing the interaction of asialo von Willebrand factor with human platelets--the effects of external ionized calcium concentration and the role of arachidonate pathway. |
1988 |
Thromb. Haemost. |
pmid:3146144
|
Fimognari FL et al. |
Nocturnal rise of urinary thromboxane B 2 in patients with coronary artery disease. |
2005 |
Thromb. Haemost. |
pmid:15735822
|
De Caterina R et al. |
Organic nitrates: direct antiplatelet effects and synergism with prostacyclin. Antiplatelet effects of organic nitrates. |
1988 |
Thromb. Haemost. |
pmid:3291182
|
Teng CM and Ko FN |
Comparison of the platelet aggregation induced by three thrombin-like enzymes of snake venoms and thrombin. |
1988 |
Thromb. Haemost. |
pmid:3291184
|
de Castellarnau C et al. |
Prostacyclin and thromboxane production by autogenous femoral veins grafted into the arterial circulation of the dog. |
1989 |
Thromb. Haemost. |
pmid:2665174
|
Davì G et al. |
Demonstration of Rickettsia Conorii-induced coagulative and platelet activation in vivo in patients with Mediterranean spotted fever. |
1995 |
Thromb. Haemost. |
pmid:8584998
|
Habib A et al. |
Increased expression of inducible cyclooxygenase-2 in human endothelial cells by antiphospholipid antibodies. |
1995 |
Thromb. Haemost. |
pmid:8585020
|
Evangelista V et al. |
Defibrotide inhibits platelet activation by cathepsin G released from stimulated polymorphonuclear leukocytes. |
1992 |
Thromb. Haemost. |
pmid:1509406
|
Pettinella C et al. |
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. |
2009 |
Thromb. Haemost. |
pmid:19350112
|
Totani L et al. |
Prasugrel inhibits platelet-leukocyte interaction and reduces inflammatory markers in a model of endotoxic shock in the mouse. |
2012 |
Thromb. Haemost. |
pmid:22436970
|
Véricel E et al. |
Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients. |
2015 |
Thromb. Haemost. |
pmid:25832443
|
Spowart K et al. |
Haemostatic effects of ketorolac with and without concomitant heparin in normal volunteers. |
1988 |
Thromb. Haemost. |
pmid:3266379
|
Cerletti C et al. |
Aspirin kinetics and inhibition of platelet thromboxane generation-relevance for a solution of the "aspirin dilemma". |
1985 |
Thromb. Haemost. |
pmid:4049312
|
Dotevall A et al. |
Cigarette smoking increases thromboxane A2 formation without affecting platelet survival in young healthy females. |
1992 |
Thromb. Haemost. |
pmid:1455405
|
de Boer A et al. |
Interaction study between Org 10172, a low molecular weight heparinoid, and acetylsalicylic acid in healthy male volunteers. |
1991 |
Thromb. Haemost. |
pmid:1722918
|
Davì G et al. |
Influence of metabolic control on thromboxane biosynthesis and plasma plasminogen activator inhibitor type-1 in non-insulin-dependent diabetes mellitus. |
1996 |
Thromb. Haemost. |
pmid:8819248
|
Forastiero R et al. |
Anti-beta2 glycoprotein I antibodies and platelet activation in patients with antiphospholipid antibodies: association with increased excretion of platelet-derived thromboxane urinary metabolites. |
1998 |
Thromb. Haemost. |
pmid:9459320
|
Carter AJ and Hanley SP |
The effect of platelet number and haematocrit on whole blood thromboxane synthesis. |
1985 |
Thromb. Haemost. |
pmid:4024033
|
Schorer AE |
Discordant effects on eicosanoids and fibrin degradation products in two murine models of antiphospholipid antibody. |
1997 |
Thromb. Res. |
pmid:9062953
|
Watanabe T et al. |
Enhanced platelet sensitivity to prostacyclin in patients in an active stage of Takayasu arteritis. |
2001 |
Thromb. Res. |
pmid:11672751
|
Carroll RC et al. |
Post interventional cardiology urinary thromboxane correlates with PlateletMapping detected aspirin resistance. |
2010 |
Thromb. Res. |
pmid:19962724
|
Ziegler BK et al. |
Incomplete thromboxane inhibition with 100 mg of intravenous acetylsalicylic acid in patients with acute ST elevation myocardial infarction: a placebo-controlled pilot trial. |
2001 |
Thromb. Res. |
pmid:11672759
|
Ersöz G et al. |
The effect of submaximal exercise on platelet aggregation during late follicular and midluteal phases in women. |
2002 |
Thromb. Res. |
pmid:12590951
|
Kawamura M et al. |
Evaluation of plasma 11-dehydro-thromboxane B2 as an indicator for thromboxane A2 synthesis in vivo in laboratory animals. |
1995 |
Thromb. Res. |
pmid:7778061
|
Ersöz G et al. |
Effect of sodium selenite treatment on platelet aggregation of streptozotocin-induced diabetic rats. |
2003 |
Thromb. Res. |
pmid:14698654
|
Teng CM et al. |
Two antiplatelet agents from Magnolia officinalis. |
1988 |
Thromb. Res. |
pmid:3413728
|
Addonizio VP et al. |
Inhibition of human platelet function by verapamil. |
1982 |
Thromb. Res. |
pmid:7164035
|
Vargaftig BB et al. |
Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets. |
1982 |
Thromb. Res. |
pmid:7164036
|
Vlodavsky I et al. |
Platelet interaction with the extracellular matrix produced by cultured endothelial cells: a model to study the thrombogenicity of isolated subendothelial basal lamina. |
1982 |
Thromb. Res. |
pmid:7179215
|
Cholette JM et al. |
Aspirin resistance following pediatric cardiac surgery. |
2010 |
Thromb. Res. |
pmid:20550971
|
Umemura K et al. |
Effect of dietary docosahexaenoic acid in the rat middle cerebral artery thrombosis model. |
1995 |
Thromb. Res. |
pmid:7660354
|
Carter AJ et al. |
Human pulmonary vessels obtained from necropsy produce less prostacyclin and thromboxane than fresh vessels obtained from operations. |
1984 |
Thromb. Res. |
pmid:6547546
|
Rousson D et al. |
Acute myocardial infarction: measurement of arachidonate end-products in whole blood as an index of platelet cyclo-oxygenase activity in vivo. |
1987 |
Thromb. Res. |
pmid:3122356
|
Hanasaki K and Arita H |
Characterization of a new compound, S-145, as a specific TXA2 receptor antagonist in platelets. |
1988 |
Thromb. Res. |
pmid:2839912
|
Navran SS et al. |
Human platelet activation by bacterial phospholipase C is mediated by phosphatidylinositol hydrolysis but not generation of phosphatidic acid: inhibition by a selective inhibitor of phospholipase C. |
1984 |
Thromb. Res. |
pmid:6372157
|
Ishikawa Y et al. |
Effect of cytoplasmic pH on platelet activation by arachidonic acid. |
1989 |
Thromb. Res. |
pmid:2499076
|
Lages B and Weiss HJ |
Inhibition of human platelet function in vitro and ex vivo by acetaminophen. |
1989 |
Thromb. Res. |
pmid:2499947
|
Küster LJ et al. |
Mechanism of PAF-induced platelet aggregation in man. |
1986 |
Thromb. Res. |
pmid:3764802
|
Reimers HJ et al. |
Impaired thromboxane synthesis in preactivated human blood platelets: agonist-specific, irreversible desensitization to thrombin. |
1987 |
Thromb. Res. |
pmid:3126557
|
Mercer JB et al. |
The effect of short-term cold exposure on risk factors for cardiovascular disease. |
1999 |
Thromb. Res. |
pmid:10418798
|
Perneby C et al. |
Prothrombotic responses to exercise are little influenced by clopidogrel treatment. |
2004 |
Thromb. Res. |
pmid:15381386
|
Hall ER et al. |
The reduction of platelet thrombi on damaged vessel wall by a thromboxane synthetase inhibitor in rabbits. |
1982 |
Thromb. Res. |
pmid:6891109
|
Lukasik M et al. |
Aspirin treatment influences platelet-related inflammatory biomarkers in healthy individuals but not in acute stroke patients. |
2011 |
Thromb. Res. |
pmid:21788065
|
Udvardy M et al. |
Alterations of primary haemostasis in mixed connective tissue disease (MCTD). |
1991 |
Thromb. Res. |
pmid:1835548
|
Marasini B et al. |
Cigarette smoking and platelet function. |
1986 |
Thromb. Res. |
pmid:3787563
|
Deckmyn H et al. |
Prostacyclin production by whole blood from children: impairment in the hemolytic uremic syndrome and excessive formation in chronic renal failure. |
1983 |
Thromb. Res. |
pmid:6344317
|
Neiman J et al. |
Composition of platelet phosphatidylinositol and phosphatidylcholine after ethanol withdrawal. |
1987 |
Thromb. Res. |
pmid:3603426
|
Vesterqvist O et al. |
Development of a GC-MS method for quantitation of 2,3-dinor-TxB2 and determinations of the daily urinary excretion rates in healthy humans. |
1984 |
Thromb. Res. |
pmid:6695361
|
Todd MK et al. |
Effect of exercise intensity on 6-keto-PGF1 alpha, TXB2, and 6-keto-PGF1 alpha/TXB2 ratios. |
1992 |
Thromb. Res. |
pmid:1615492
|
Dembinska-Kiec A et al. |
Ticlopidine and platelet function in healthy volunteers. |
1992 |
Thromb. Res. |
pmid:1615496
|
Maguire ED and Wallis RB |
In vivo redirection of prostaglandin endoperoxides into 6-keto PGF1 alpha formation by thromboxane synthetase inhibitors in the rat. |
1983 |
Thromb. Res. |
pmid:6689221
|
Ames PR et al. |
Aspirin insensitive thromboxane generation is associated with oxidative stress in type 2 diabetes mellitus. |
2012 |
Thromb. Res. |
pmid:22521214
|
Vesterqvist O et al. |
In vivo production of thromboxane in acute human myocardial infarction: a preliminary study. |
1985 |
Thromb. Res. |
pmid:3992528
|
Chiang TM and Kang AH |
The effect of platelet surface protein phosphorylation on collagen-platelet interaction. |
1986 |
Thromb. Res. |
pmid:3810565
|
Hofmann D et al. |
Evidence for sustained platelet activation in patients with early postinfarction angina. |
1993 |
Thromb. Res. |
pmid:8303651
|
Knapp HR et al. |
Effects of low-dose aspirin on endogenous eicosanoid formation in normal and atherosclerotic men. |
1988 |
Thromb. Res. |
pmid:3293263
|
Selley ML et al. |
The effect of cholesterol oxidation products on human platelet aggregation. |
1996 |
Thromb. Res. |
pmid:8885139
|
Kritz H et al. |
Isradipine increases vascular prostaglandin I2-formation while the thromboxane B2-synthesis is diminished. |
1995 |
Thromb. Res. |
pmid:8610276
|
Bergqvist D et al. |
The effect of inhibition of thromboxane synthesis in experimental thrombosis and hemostasis. |
1985 |
Thromb. Res. |
pmid:3838828
|
Domoto DT et al. |
Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis. |
1991 |
Thromb. Res. |
pmid:1926064
|
Küster LJ and Frölich JC |
PAF-induced platelet aggregation and TXB2 formation. |
1989 |
Thromb. Res. |
pmid:2922704
|
Antonino MJ et al. |
Antiplatelet effects of aspirin with phytosterols: comparison with non-enteric coated aspirin alone. |
2010 |
Thromb. Res. |
pmid:19446864
|
Altman R et al. |
Why single daily dose of aspirin may not prevent platelet aggregation. |
1988 |
Thromb. Res. |
pmid:3140408
|
Simmet T and Weide I |
Thromboxane and cysteinyl-leukotriene formation are differentially activated in spontaneously clotting whole human blood in vitro. |
1991 |
Thromb. Res. |
pmid:1866709
|
Meyers KM et al. |
An evaluation of the arachidonate pathway of platelets from companion and food-producing animals, mink, and man. |
1980 |
Thromb. Res. |
pmid:7209869
|